These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33515341)

  • 21. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities.
    Bonci D; Coppola V; Musumeci M; Addario A; Giuffrida R; Memeo L; D'Urso L; Pagliuca A; Biffoni M; Labbaye C; Bartucci M; Muto G; Peschle C; De Maria R
    Nat Med; 2008 Nov; 14(11):1271-7. PubMed ID: 18931683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting cell cycle protein in gastric cancer with CDC20siRNA and anticancer drugs (doxorubicin and quercetin) co-loaded cationic PEGylated nanoniosomes.
    Hemati M; Haghiralsadat F; Jafary F; Moosavizadeh S; Moradi A
    Int J Nanomedicine; 2019; 14():6575-6585. PubMed ID: 31616144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simvastatin Treatment Protects Myocardium in Noncoronary Artery Cardiac Surgery by Inhibiting Apoptosis Through miR-15a-5p Targeting.
    Zhou L; Liu X; Wang ZQ; Li Y; Shi MM; Xu Z; Ou ZJ; Li HM; Cheng TP; Jian YP; Zhang W; Liu C; Zhang X; Quon MJ; Zhang CX; Xu YQ; Wang ZP; Ou JS
    J Cardiovasc Pharmacol; 2018 Oct; 72(4):176-185. PubMed ID: 29985281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner.
    Bandi N; Vassella E
    Mol Cancer; 2011 May; 10():55. PubMed ID: 21575235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of recombinant lentiviral vector encoding miR-15a/16-1 in biological features of human nasopharyngeal carcinoma CNE-2Z cells.
    Zhang C; Fang X; Li W; Shi Q; Wu L; Chen X; Huang Z; Wu P; Wang Z; Liao Z
    Cancer Biother Radiopharm; 2014 Dec; 29(10):422-7. PubMed ID: 25405832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-15a Participated in the Pathogenesis of Pterygium via Targeting BCL-2
    Shen J; Li H; Chen Y; Jiang B; Zhu M; Feng S; Cui H
    Curr Eye Res; 2022 Jan; 47(1):32-40. PubMed ID: 34225531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-15a induces cell apoptosis by targeting BCL2L2 and BCL2 in HPV-positive hypopharyngeal squamous cell carcinoma.
    Lu W; Feng L; Zhang Y; Ma Y; Li P; Wang Y; Du Y; Chen X; Wu S; Zhao G; Lou W
    Oncol Rep; 2016 Oct; 36(4):2169-76. PubMed ID: 27573302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. microRNA-205 and microRNA-338-3p Reduces Cell Apoptosis in Prostate Carcinoma Tissue and LNCaP Prostate Carcinoma Cells by Directly Targeting the B-Cell Lymphoma 2 (Bcl-2) Gene.
    Zhang X; Pan Y; Fu H; Zhang J
    Med Sci Monit; 2019 Feb; 25():1122-1132. PubMed ID: 30741252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of miR-221, -30d, and -15a contributes to pathogenesis of prostate cancer by targeting Bmi-1.
    Xuan H; Xue W; Pan J; Sha J; Dong B; Huang Y
    Biochemistry (Mosc); 2015 Mar; 80(3):276-83. PubMed ID: 25761682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression.
    Corcoran C; Rani S; O'Driscoll L
    Prostate; 2014 Sep; 74(13):1320-34. PubMed ID: 25053345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversing multidrug resistance in Caco-2 by silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL using liposomal antisense oligonucleotides.
    Lo YL; Liu Y
    PLoS One; 2014; 9(3):e90180. PubMed ID: 24637737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selenium nanoparticles (SeNPs) have potent antitumor activity against prostate cancer cells through the upregulation of miR-16.
    Liao G; Tang J; Wang D; Zuo H; Zhang Q; Liu Y; Xiong H
    World J Surg Oncol; 2020 May; 18(1):81. PubMed ID: 32357938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour suppressor properties of miR-15a and its regulatory effects on BCL2 and SOX2 proteins in colorectal carcinomas.
    Gopalan V; Ebrahimi F; Islam F; Vider J; Qallandar OB; Pillai S; Lu CT; Lam AK
    Exp Cell Res; 2018 Sep; 370(2):245-253. PubMed ID: 29958837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells.
    Kharaziha P; Rodriguez P; Li Q; Rundqvist H; Björklund AC; Augsten M; Ullén A; Egevad L; Wiklund P; Nilsson S; Kroemer G; Grander D; Panaretakis T
    Cell Death Dis; 2012 Jan; 3(1):e262. PubMed ID: 22278289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-15a/16 regulates the growth of myeloma cells, angiogenesis and antitumor immunity by inhibiting Bcl-2, VEGF-A and IL-17 expression in multiple myeloma.
    Li Y; Zhang B; Li W; Wang L; Yan Z; Li H; Yao Y; Yao R; Xu K; Li Z
    Leuk Res; 2016 Oct; 49():73-9. PubMed ID: 27596960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-1266-5p and miR-185-5p Promote Cell Apoptosis in Human Prostate Cancer Cell Lines.
    Ostadrahimi S; Abedi Valugerdi M; Hassan M; Haddad G; Fayaz S; Parvizhamidi M; Mahdian R; Fard Esfahani P
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2305-2311. PubMed ID: 30141307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of Bcl-2 siRNA combined with miR-15a oligonucleotides on the growth of Raji cells.
    Hu X; Li W; Liu G; Wu H; Gao Y; Chen S; He D; Zhang Y
    Med Oncol; 2013 Mar; 30(1):430. PubMed ID: 23307249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted delivery of miRNA-204-5p by PEGylated polymer nanoparticles for colon cancer therapy.
    Zheng B; Chen L; Pan CC; Wang JZ; Lu GR; Yang SX; Xue ZX; Wang FY; Xu CL
    Nanomedicine (Lond); 2018 Apr; 13(7):769-785. PubMed ID: 29460671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bcl-xL silencing induces alterations in hsa-miR-608 expression and subsequent cell death in A549 and SK-LU1 human lung adenocarcinoma cells.
    Othman N; In LL; Harikrishna JA; Hasima N
    PLoS One; 2013; 8(12):e81735. PubMed ID: 24339958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ABL-N may induce apoptosis of human prostate cancer cells through suppression of KLF5, ICAM-1 and Stat5b, and upregulation of Bax/Bcl-2 ratio: An in vitro and in vivo study.
    Zhang Y; Liu K; Zhang Y; Qi J; Lu B; Shi C; Yin Y; Cai W; Li W
    Oncol Rep; 2015 Dec; 34(6):2953-60. PubMed ID: 26397390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.